Blog • Articoli • Obesità e sovrappeso
Dr. Ahmed Abdel Samie-Huber
M.D., AGAF, FACP, FEBGH, FEFIM, Chief Medical Officer, YouAre
Gli agonisti del recettore del peptide-1 simile al glucagone (GLP-1 RA) sono promettenti agenti terapeutici recentemente approvati per la gestione dell'obesità e delle complicazioni metaboliche correlate all'obesità. Wegovy: un RA GLP-1 approvato per la gestione dell'obesità.
Letteratura
Patient motivation to lose weight: importance of healthcare professional support, goals and self-efficacy, Dicker D, Alfadda AA, Coutinho W, Cuevas A, Halford JCG, Hughes CA et al Eur J Intern Med 2021; 91:10–16
Developing a holistic approach to obesity management, Brown J, Wimpenny P, Int J Nurs Pract. 2011 Feb;17(1):9-18
Advancements in the management of obesity: a review of current evidence and emerging therapies, Abdalla Ahmed MA, Ssemmondo E, Mark-Wagstaff C, Sathyapalan T, Expert Rev Endocrinol Metab. 2024 May;19(3):257-268
Weight Loss Programs: Why Do They Fail? A Multidimensional Approach for Obesity Management, Rabie Khattab, Curr Nutra Rep. 2024 Sep;13(3):478-499
Research Trends in Motivation and Weight Loss: A Bibliometric-Based Review, Železnik U, Kokol P, Starc J, Železnik D, Završnik J, Vošner HB, Healthcare (Basel). 2023 Dec 1;11(23):3086
Determining factors required for a holistic approach to weight management of those with obesity, Jenny Brown , Peter Wimpenny, ANS Adv Nurs Sci. 2011 Apr-Jun;34(2):136-50
Addressing psychosocial health in the treatment and care of adolescents with obesity, Jebeile H, Cardel MI, Kyle TK, Jastreboff AM, Obesity (Silver Spring). 2021 Sep;29(9):1413-1422